Author

Jennii Luu

Peter MacCallum Cancer CentreORCID 0000-0002-5875-4820Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:organoid / primary culture· 1 Assay:proteomics· 1

Frequent Co-Authors

Karla J. CowleyiD· 2 shared Kaylene J. SimpsoniD· 2 shared Alicia OshlackiD· 1 shared Andrew J. DeansiD· 1 shared Anna DeFazioiD· 1 shared Breana Galea· 1 shared Briony Milesi· 1 shared Carolina SalazariD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Karla J. CowleyORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Fanconi Anaemia E3 Ligase complex activity is regulated by a druggable metabolite binding site in FANCX

Michael F. Sharp, Yi Sing Gee, Jennii Luu, Karla J. Cowley, Henry G. Beetham, Christopher G. Langendorf, Jonathan S. Oakhill, John W. Scott, Debora Cavero, Jordi Minguillón, Daqing Che, Jonathan B. Baell, Andrew J. Deans, Jordi Surrallés, Kaylene J. Simpson, Wayne Crismani

The paper identifies a druggable metabolite binding site in the FA E3 ligase complex that inhibits its activity and selectively kills BRCA1-deficient cells.

bioRxiv · Aug 7, 2026 · PreprintCancer Biology

Comprehensive drug efficacy data for mucinous ovarian carcinoma using a novel and extensive biobank of patient-derived organoid models

Olivia Craig, Carolina Salazar, Suad M. Abdirahman, Nikita Dalvi, Niveditha Rajadevan, Jennii Luu, Robert Vary, Susanne Ramm, Karla J. Cowley, Ratana Lim, Briony Milesi, Christopher Tagkalidis, Patricia Wojtowicz, Stuart Bencraig, Genevieve Dall, , Kylie L. Gorringe

This paper develops a large biobank of patient-derived MOC organoids and screens them for drug efficacy, finding resistance to standard therapies and effectiveness of less commonly used drugs.

bioRxiv · Apr 9, 2026 · PreprintCancer Biology